Genetic diagnostic and drug discovery research firm MedGeneome Labs claimed to have developed the first whole genomic sequencing-based test to detect early drug-resistant mutation in tuberculosis (TB) bacteria. The breakthrough DNA test will enable a doctor to correctly prescribe the most effective drug to a TB patient without a time-consuming trial and error process said the city-based clinical data-driven Labs. Announcing its foray into infectious disease testing in TB central nervous system (CNS) systemic and eye infections the company said India had the largest number of multi-drug resistant (MDR) TB cases. India has the largest number of MDR-TB cases. Our